Cardinal Health Rises 1.24% Despite Diving Trading Volume to $510M 234th in Market Activity

Cardinal Health (CAH) rose 1.24% on August 13, 2025, despite a 54.63% drop in daily trading volume to $510 million, ranking 234th in market activity. The healthcare distributor released fourth-quarter and fiscal year 2025 results, reporting $60.2 billion in revenue, flat year-over-year but up 21% excluding the impact of a contract expiration. Non-GAAP operating earnings and EPS surged, driven by improved segment performance, while the company raised 2026 non-GAAP EPS guidance to $9.30–$9.50 and announced the acquisition of urology-focused Solaris Health to expand its specialty solutions division.

Analysts remain cautious, with the latest rating at Hold and a $110 price target. Strategic growth initiatives, including recent acquisitions and product innovations, are seen as long-term positives, though financial risks such as negative equity and valuation concerns persist. Technical indicators suggest short-term volatility, balancing optimism over earnings momentum with caution around market conditions.

The strategy of buying the top 500 stocks by daily trading volume and holding for one day from 2022 to present yielded a 6.98% CAGR, with a 15.46% maximum drawdown during the backtest period. While demonstrating steady growth, the mid-2023 downturn underscores the need for risk management in volatile markets.